Search Results - "Vera Mendoza, Maria Isabel"
-
1
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice
Published in Crohn's & colitis 360 (01-01-2023)“…Abstract Background Loss of response to anti-tumor necrosis factor drugs in patients with inflammatory bowel disease (IBD) is frequent and, in case of low drug…”
Get full text
Journal Article -
2
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease
Published in Gastroenterología y hepatología (01-08-2024)“…It is widely acknowledged that inflammatory bowel disease (IBD) is associated with a high prevalence of sexual dysfunction (SD). However, there is a notable…”
Get more information
Journal Article -
3
Risk factors for Clostridium difficile diarrhea in patients with inflammatory bowel disease
Published in Revista española de enfermedades digestivas (01-01-2015)“…Despite the growing incidence of Clostridium difficile diarrhea (CCD) in patients with inflammatory bowel disease (IBD), little is known about the associated…”
Get full text
Journal Article -
4
Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease
Published in Revista española de enfermedades digestivas (01-02-2016)“…The possibility of developing idiopathic portal hypertension has been described with thiopurine treatment despite compromises the prognosis of these patients,…”
Get full text
Journal Article -
5
Clinical characteristics and prognostic factors for Crohn’s disease relapses using natural language processing and machine learning: a pilot study
Published in European journal of gastroenterology & hepatology (01-04-2022)“…The impact of relapses on disease burden in Crohn's disease (CD) warrants searching for predictive factors to anticipate relapses. This requires analysis of…”
Get full text
Journal Article -
6
Risk of thromboembolic phenomena in patients with inflammatory bowel disease
Published in Gastroenterología y hepatología (01-11-2012)“…Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors…”
Get more information
Journal Article -
7
Utility and cost of the endoscopic capsule. Three years' experience in our center
Published in Gastroenterología y hepatología (01-03-2013)“…The aim of this study was to evaluate the safety, clinical impact and costs associated with capsule endoscopy (CE) in our center. We retrospectively analyzed…”
Get more information
Journal Article -
8
-
9
Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease
Published in Gastroenterología y Hepatología (English Edition) (01-08-2024)“…It is widely acknowledged that inflammatory bowel disease (IBD) is associated with a high prevalence of sexual dysfunction (SD). However, there is a notable…”
Get full text
Journal Article -
10
Digestive units in the National Health System of the 21st century. Organizational and management standards for a patient-centered service
Published in Revista española de enfermedades digestivas (01-02-2020)“…The Spanish Society of Digestive Pathology has set a consensus document on the standards and recommendations for gastroenterology units (GU). These standards…”
Get full text
Journal Article -
11
Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva
Published in Revista española de enfermedades digestivas (01-04-2016)“…In the last few years a significant number of papers have related the use of proton-pump inhibitors (PPIs) to potential serious adverse effects that have…”
Get full text
Journal Article -
12
El trasplante de microbiota fecal es un tratamiento sencillo, efectivo y seguro en el manejo de la infección por C.difficile en la práctica clínica diaria
Published in Enfermedades infecciosas y microbiología clínica (01-04-2023)“…El trasplante de microbiota fecal (TMF) es un tratamiento avalado por evidencia científica amplia y muy efectivo en el manejo de la infección por…”
Get full text
Journal Article -
13
-
14